ABOS - Acumen Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABOS is currently covered by 4 analysts with an average price target of $7.57. This is a potential upside of $6.21 (456.62%) from yesterday's end of day stock price of $1.36.

Acumen Pharmaceuticals's activity chart (see below) currently has 22 price targets and 27 ratings on display. The stock rating distribution of ABOS is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ABOS is $11, Lowest price target is $4, average price target is $8.

Most recent stock forecast was given by GEOFF MEACHAM from BAML on 17-Jun-2025. First documented stock forecast 26-Jul-2021.

Currently out of the existing stock ratings of ABOS, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4

$2.47 (161.44%)

$14

2 months 12 days ago
(17-Jun-2025)

0/4 (0%)

$2.78 (227.87%)

Buy

$11

$9.47 (618.95%)

5 months 1 days ago
(28-Mar-2025)

0/8 (0%)

$9.81 (824.37%)

Buy

$6

$4.47 (292.16%)

$15

1 years 14 days ago
(15-Aug-2024)

0/3 (0%)

$3.42 (132.56%)

Buy

$11

$9.47 (618.95%)

$15

1 years 5 months 2 days ago
(27-Mar-2024)

0/2 (0%)

$6.9 (168.29%)

Buy

$13

$11.47 (749.67%)

$13

2 years 20 days ago
(09-Aug-2023)

0/5 (0%)

$6.22 (91.74%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABOS (Acumen Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?

GEOFF MEACHAM

Which analyst has the current lower performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?

PETE STAVROPOULOS

Which analyst has the most public recommendations on ABOS (Acumen Pharmaceuticals)?

Geoff Meacham works at BAML and has 2 price targets and 2 ratings on ABOS

Which analyst is the currently most bullish on ABOS (Acumen Pharmaceuticals)?

Paul Matteis with highest potential upside - $11.48

Which analyst is the currently most reserved on ABOS (Acumen Pharmaceuticals)?

Geoff Meacham with lowest potential downside - $2.47

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?